University of Parma / Università degli Studi di Parma

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy (2023) Kiryluk K, Sanchez-Rodriguez E, Zhou XJ, Zanoni F, Liu L, Mladkova N, Khan A, et al. Journal article Fingerprints Indicating Superior Properties of Internal Interfaces in Cu(In,Ga)Se2 Thin-Film Solar Cells (2022) Raghuwanshi M, Chugh M, Sozzi G, Kanevce A, Kühne TD, Mirhosseini H, Wuerz R, Cojocaru-Miredin O Journal article Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project) (2022) Bernabei R, Landi F, Calvani R, Cesari M, Del Signore S, Anker SD, Bejuit R, et al. Journal article ESPEN practical guideline: Clinical nutrition and hydration in geriatrics (2022) Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Hooper L, Kiesswetter E, Maggio M, et al. Journal article Gait characteristics in community-dwelling older persons with low skeletal muscle mass and low physical performance (2022) Longobucco Y, Krumpoch S, Lauretani F, Angileri V, Sieber C, Marzetti E, Calvani R, et al. Journal article EAPC Core Curriculum for Preventive Cardiology (2022) Wilhelm M, Abreu A, Adami PE, Ambrosetti M, Antonopoulou M, Biffi A, Cavarretta E, et al. Journal article Comprehensive Raman study of orthorhombic kappa/epsilon-Ga2O3 and the impact of rotational domains (2021) Janzen BM, Mazzolini P, Gillen R, Peltason VFS, Grote LP, Maultzsch J, Fornari R, et al. Journal article Ultrafast laser manufacturing: from physics to industrial applications (2021) Orazi L, Romoli L, Schmidt M, Li L Journal article, Review article The sarcopenia and physical frailty in older people: multi-component treatment strategies (SPRINTT) project: description and feasibility of a nutrition intervention in community-dwelling older Europeans (2021) Jyvakorpi SK, Ramel A, Strandberg TE, Piotrowicz K, Blaszczyk-Bebenek E, Urtamo A, Rempe H, et al. Journal article Efficacy of Margetuximab vs Trastuzumab in Patients With Pretreated ERBB2-Positive Advanced Breast Cancer A Phase 3 Randomized Clinical Trial (2021) Rugo HS, Im SA, Cardoso F, Cortes J, Curigliano G, Musolino A, Pegram MD, et al. Journal article